Photocure to present at four investor conferences in November/December 2023

Photocure • 20 November 2023 - 18:01


Health Care/Hospitals Medical/Pharmaceuticals OTC/SmallCap Pharmaceuticals


Tradeshow News

OSLO, Norway, Nov. 20, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), The Bladder Cancer Company, announces its participation in four investor conferences focusing on the healthcare sector in Q4 2023:

The SEB Healthcare Seminar will take place in Stockholm, November 21-23, 2023. David Moskowitz, Photocure's Vice President Investor Relations will present a corporate overview on November 22 at 10:40am CET.

The 35th Annual Piper Sandler Healthcare Conference will be held in New York City, November 28-30, 2023. Dan Schneider, Photocure's President and CEO will present on November 28 at 9:50am ET. A webcast of the presentation will be available at: Photocure ASA (PHO NO) - 1644046 (

The 2023 Nordic American Healthcare Conference is scheduled to be held December 6-7 in New York City. Dan Schneider will present a corporate overview on December 6 at 2:30pm ET.

The 14th Annual DNB Nordic Healthcare Conference will be held in Oslo on December 14, 2023. Photocure's President and CEO Dan Schneider will present a corporate overview at 3:35pm CET.

For further information, please contact:

Dan Schneider

President and CEO

Photocure ASA

Email: [email protected]

Erik Dahl


Photocure ASA

Tel: +4745055000

Email: [email protected]

David Moskowitz

Vice President, Investor Relations

Photocure ASA

Tel: +1 202 280 0888

Email: [email protected]

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

Email: [email protected]

The following files are available for download:



Cision View original content:

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.